13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand B6/2

2022 Edition

Domain Therapeutics

fr

Domain Therapeutics is a clinical-stage biotech delivering immunotherapies targeting GPCR-mediated immunosuppression. Our high-value proprietary programs consist of first-in-class and best-in-class strategically positioned assets regarding tumor subtypes and patient subpopulations for optimal outcome.

Scroll to Top
  • No products in the cart.